• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

Recent Advances in the Study of tert-Butyl N-({6-Azabicyclo[3.2.1]octan-5-yl}methyl)carbamate (CAS: 1439908-26-5)

The compound tert-butyl N-({6-azabicyclo[3.2.1]octan-5-yl}methyl)carbamate (CAS: 1439908-26-5) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and therapeutic potential.

Recent studies have highlighted the unique structural features of tert-butyl N-({6-azabicyclo[3.2.1]octan-5-yl}methyl)carbamate, which make it a promising scaffold for the design of novel bioactive molecules. The 6-azabicyclo[3.2.1]octane core is particularly noteworthy for its conformational rigidity and ability to mimic natural peptide motifs, making it an attractive target for medicinal chemists.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the efficient synthesis of tert-butyl N-({6-azabicyclo[3.2.1]octan-5-yl}methyl)carbamate via a multi-step process involving key intermediates. The study reported a high-yield route that could be scaled up for industrial production, addressing previous challenges in the compound's accessibility.

Pharmacological evaluations have revealed that derivatives of tert-butyl N-({6-azabicyclo[3.2.1]octan-5-yl}methyl)carbamate exhibit significant binding affinity to various biological targets. Notably, a series of analogs showed potent activity against neurological receptors, suggesting potential applications in the treatment of central nervous system disorders. Molecular docking studies have provided insights into the structural requirements for optimal target engagement.

Ongoing research is exploring the compound's utility as a building block for more complex pharmaceutical agents. Its chemical versatility allows for diverse modifications at multiple positions, enabling the creation of libraries of compounds for high-throughput screening. Several pharmaceutical companies have included this scaffold in their drug discovery pipelines, particularly for neurodegenerative diseases and pain management.

The stability and pharmacokinetic properties of tert-butyl N-({6-azabicyclo[3.2.1]octan-5-yl}methyl)carbamate derivatives have been investigated in recent preclinical studies. Initial results indicate favorable metabolic stability and blood-brain barrier penetration, which are crucial factors for CNS-targeted therapeutics. However, further optimization is needed to improve bioavailability and reduce potential off-target effects.

In conclusion, tert-butyl N-({6-azabicyclo[3.2.1]octan-5-yl}methyl)carbamate (CAS: 1439908-26-5) represents a valuable chemical entity with broad potential in medicinal chemistry. The latest research underscores its importance as a versatile scaffold for drug discovery, particularly in neurological applications. Future studies should focus on expanding the structure-activity relationship profile and advancing promising derivatives through clinical development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)